ISRAEL INNOVATION PROJECT

Four Israeli founded technology companies have been recognized in TIME magazine’s 2026 Best Inventions list, which highlights 300 innovations making an impact around the world. The featured technologies include AI powered robotic beehives that help protect honeybee populations, trained dogs that detect cancer related signals in human breath, medical AI that identifies urgent findings in scans, and a tool that helps artists receive royalties when their work is used in AI generated content. The recognition highlights how Israeli innovators are developing practical solutions across healthcare, sustainability, and responsible AI.

As artificial intelligence reshapes Israel’s technology sector, universities are seeing growing student interest in electrical and electronics engineering, which supports the chips and hardware behind AI systems. At the same time, enrollment in computer science has declined, reflecting changing expectations about future technology jobs and the growing importance of specialized technical skills. Israeli higher education institutions are expanding AI degree programs and investing in computing infrastructure to prepare students for an evolving industry. The shift highlights how the AI boom is influencing both career choices and the skills needed for Israel’s future workforce.

The Israel US Binational Industrial Research and Development Foundation is investing $7.4 million in seven joint American and Israeli technology projects, with additional private sector funding potentially bringing their combined value to $20 million. The projects include technologies for earlier cancer detection, 3D printed orthopedic tools, and artificial intelligence-powered seed sorting. The initiative supports collaboration between companies in both countries to develop new commercial technologies across fields such as healthcare and advanced manufacturing, strengthening the partnership between the two innovation ecosystems.

Shaare Zedek Medical Center in Jerusalem has become the first hospital in Israel to use the ILY robotic system for treating kidney stones. The technology allows surgeons to control an instrument inside the urinary tract with greater precision using a wireless remote and laser, potentially improving procedural control and making treatment more efficient. Israel is among a small number of countries using the system, marking another advance in the adoption of robotic technology for minimally invasive urological procedures.

Researchers at Ben Gurion University of the Negev have identified two proteins that help cancer cells survive chemotherapy by activating a cellular defense mechanism that prevents them from self-destructing. The discovery reveals a previously unknown way tumors can resist treatment and suggests that disrupting these protective proteins could make cancer cells more vulnerable to chemotherapy. The findings offer a potential new direction for developing treatments against aggressive cancers, although further research is needed to determine how the mechanism could be targeted safely and effectively in patients.

Researchers at the Weizmann Institute of Science have uncovered a possible evolutionary tradeoff that helped shape modern humans: changes in genes responsible for producing molecules that cushion joints may also have contributed to the development of more flexible, adaptable brains. By comparing human genetics with those of other primates, the international research team found that reduced levels of these molecules may have supported greater brain plasticity while leaving human joints more vulnerable to wear and degeneration. The findings offer new insight into human evolution and could eventually help researchers develop treatments for conditions such as osteoarthritis.

A Hebrew University study has found that Israeli combat reservists who experienced greater exposure to combat reported more severe PTSD symptoms, depression, and problematic drinking, with the strongest associations appearing among those who support opposition parties. Researchers suggest that political beliefs, social connections, and a sense of shared meaning may influence how veterans cope with trauma. The findings highlight the importance of understanding the social and psychological factors that can shape mental health and inform more effective support for combat veterans.

Israeli biotechnology company MediWound has launched an international clinical trial to evaluate EscharEx, an investigational treatment for chronic wounds that fail to heal. Building on technology originally developed to remove damaged tissue from severe burns, the treatment aims to help prepare persistent wounds for healing while minimizing harm to surrounding healthy tissue. The study plans to enroll 216 patients across medical centers in Israel, the United States, and Europe. If successful, the treatment could offer a new option for patients whose chronic wounds can cause serious complications, including infections and amputations.

Dognosis, an Israeli co-founded startup in Bengaluru, is training rescue dogs like Chloe, a Labrador mix, to sniff out cancer using AI. The dogs wear sensor-packed helmets tracking brain activity, respiration, and body language as they smell a patient's breath sample, collected via a cotton mask with no direct contact. Dogs have roughly 300 million scent receptors versus five million in humans, and disease is known to alter body odor. In a study of over 1,500 participants across six hospitals, Dognosis reported 90% accuracy detecting seven cancer types. It hopes to launch commercially next year, becoming the third such company after firms in Germany and Israel. Independent Bengaluru oncologists called the results a promising early signal but said larger studies are still needed.

Researchers at Tel Aviv University have developed a fast, $60 blood test that detected stage 2 through 4 lung cancer with 93% accuracy in a study of 103 participants, without relying on expensive DNA sequencing. Using fluorescent light to identify cancer-related chemical changes in DNA fragments found in the bloodstream, the test could offer a simpler and more affordable way to diagnose and monitor lung cancer. A larger trial is now underway in hospitals in Israel and Europe, with researchers hoping the technology could eventually help detect the disease earlier, when treatment is most effective.